Immunovant presents at J.P. Morgan Healthcare Conference with new corporate deck; no specific data disclosed

Immunovant, Inc.

Presentation at 41st Annual J.P. Morgan Healthcare Conference beginning January 9, 2023.
New corporate presentation provided to investors; no clinical or financial updates in filing.
Filing does not contain specific new data or material changes to pipeline or guidance.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.